GUJTHEM Share Price Target 2028

CAGR-based price projection for Gujarat Themis Biosyn Limited (GUJTHEM) targeting 2028, derived from official NSE exchange closing prices.

Bear Case (13.5% CAGR)
Rs 492
2028 Target
Base Case (33.7% CAGR)
Rs 682
2028 Target
Bull Case (102.2% CAGR)
Rs 1,561
2028 Target

Current Market Snapshot

CMP: Rs 381.80
52W High: Rs 453.25
52W Low: Rs 282.97
1Y CAGR: 78.6%
3Y CAGR: 33.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 433 Rs 510 Rs 772
2028 Rs 492 Rs 682 Rs 1,561

Other GUJTHEM Price Targets

2025 2026 2027 2030 2035 2040 2050

Frequently Asked Questions

What is the GUJTHEM share price target for 2028?

Based on historical growth analysis, the GUJTHEM share price target for 2028 ranges from Rs 492 (conservative) to Rs 682 (base case) to Rs 1,561 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of GUJTHEM?

The current market price of GUJTHEM (Gujarat Themis Biosyn Limited) is Rs 381.80. The 52-week high is Rs 453.25 and 52-week low is Rs 282.97.

Is GUJTHEM a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for GUJTHEM price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 13.5% CAGR), Base (33.7% CAGR), and Bull (optimistic at 102.2% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.